First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
Taking a multi-disciplinary approach to ongoing pain management and opioid recovery
Following up on comments received at their June 25, 2020, hearing, the Industrial Commission of Arizona released a revised version of their draft f
Over the last decade, the insurance industry has undergone dramatic changes that have catapulted it to the forefront of the American consciousness,
Part Two: Evaluating In-Network and Out-of-Network Trends As part of our ongoing drug trends series, in part two of our analysis w
Keep current with new legislation and its potential effect on your organization.
In 2019, the top 10 therapeutic classes accounted for 76.8% of all scripts and 79.6% of all costs.